… (GBD) data for 2020 from 204 countries indicates that the COVID-19 pandemic and
associated lockdowns increased the prevalence of anxiety and depressive disorders worldwide. …

… COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety
disorders … the burden of major depressive disorder and anxiety disorders due to the COVID-…

… underlying post-COVID-19 depressive symptoms are mainly related to … COVID-19 depressive
symptoms may significantly increase the pool of people suffering from depressive disorders…

… The current study focuses on major depressive disorder (MDD), which is characterized by a
period of at least 2 weeks during which there is either depressed mood or the loss of interest …

… multiple waves of COVID-19. In this study, we examined depression in relation to COVID-19
using data from the nationally representative Canadian Survey on COVID-19 and Mental …

… The COVID-19 pandemic is associated with an increased … on stable patients with major
depressive disorder (MDD) has … clinically stable MDD patients during the COVID-19 pandemic. …

… mental disorders' prevalence increased during the COVID-19 pandemic, … depression,
anxiety, and stress disorder diagnoses in General Practitioner (GP) practices during the COVID-19 …

… to explain COVID-19's global research status on depression and provide researchers with
a guide to identify future research directions. Relevant studies on depression and COVID-19 …

… disorder or a depressive disorder and those who sought mental health services. During August
19… with symptoms of an anxiety or a depressive disorder during the past 7 days increased …

… etiopathogenesis of depressive disorders. In addition, symptoms after a COVID-19 infection
may persist for up to several weeks after an acute infection as a post-COVID-19 syndrome. …